Troy Asset Management Ltd lessened its holdings in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 12.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 517,282 shares of the financial services provider's stock after selling 70,614 shares during the period. CME Group makes up 3.7% of Troy Asset Management Ltd's portfolio, making the stock its 10th biggest position. Troy Asset Management Ltd owned approximately 0.14% of CME Group worth $114,138,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. Norden Group LLC acquired a new position in CME Group during the first quarter worth $274,000. Empowered Funds LLC increased its position in CME Group by 24.5% during the first quarter. Empowered Funds LLC now owns 5,596 shares of the financial services provider's stock worth $1,205,000 after buying an additional 1,101 shares during the last quarter. QRG Capital Management Inc. raised its stake in CME Group by 1.1% in the first quarter. QRG Capital Management Inc. now owns 31,412 shares of the financial services provider's stock valued at $6,763,000 after buying an additional 346 shares during the period. US Bancorp DE lifted its position in shares of CME Group by 4.4% in the first quarter. US Bancorp DE now owns 402,285 shares of the financial services provider's stock valued at $86,608,000 after buying an additional 17,102 shares during the last quarter. Finally, Avantax Advisory Services Inc. boosted its stake in shares of CME Group by 4.5% during the 1st quarter. Avantax Advisory Services Inc. now owns 7,415 shares of the financial services provider's stock worth $1,596,000 after acquiring an additional 318 shares during the period. 87.75% of the stock is currently owned by institutional investors and hedge funds.
A number of equities analysts have commented on CME shares. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $235.00 price objective on shares of CME Group in a research report on Thursday, October 24th. TD Cowen assumed coverage on shares of CME Group in a report on Thursday, September 26th. They issued a "hold" rating and a $221.00 price target on the stock. Citigroup upped their target price on CME Group from $250.00 to $255.00 and gave the company a "buy" rating in a research report on Thursday, October 24th. Redburn Atlantic cut CME Group from a "buy" rating to a "neutral" rating and set a $244.00 price target for the company. in a report on Tuesday, October 8th. Finally, Deutsche Bank Aktiengesellschaft upped their price objective on CME Group from $193.00 to $200.00 and gave the company a "hold" rating in a report on Thursday, August 15th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and four have issued a buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus price target of $222.73.
Check Out Our Latest Research Report on CME
CME opened at $225.66 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.09. The stock has a market capitalization of $81.26 billion, a P/E ratio of 23.73, a PEG ratio of 5.56 and a beta of 0.55. The stock has a 50-day moving average price of $221.72 and a 200-day moving average price of $209.91. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $230.36.
CME Group (NASDAQ:CME - Get Free Report) last released its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. The firm's quarterly revenue was up 18.4% compared to the same quarter last year. During the same quarter last year, the firm earned $2.25 EPS. Equities analysts predict that CME Group Inc. will post 10.23 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Monday, December 9th will be issued a dividend of $1.15 per share. The ex-dividend date is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.04%. CME Group's dividend payout ratio is presently 48.37%.
In related news, Director Martin J. Gepsman sold 400 shares of the company's stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the transaction, the director now owns 25,067 shares in the company, valued at $5,587,935.64. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. In other CME Group news, Director Martin J. Gepsman sold 400 shares of the company's stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the transaction, the director now owns 25,067 shares in the company, valued at approximately $5,587,935.64. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Timothy Francis Mccourt sold 1,374 shares of the company's stock in a transaction on Monday, October 28th. The stock was sold at an average price of $227.12, for a total value of $312,062.88. Following the completion of the sale, the insider now directly owns 7,275 shares in the company, valued at approximately $1,652,298. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 15,621 shares of company stock valued at $3,441,063 in the last 90 days. Insiders own 0.30% of the company's stock.
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.